Uğur Eskiocak

1.6k total citations
30 papers, 938 citations indexed

About

Uğur Eskiocak is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Uğur Eskiocak has authored 30 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Oncology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Uğur Eskiocak's work include Genetic factors in colorectal cancer (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and CAR-T cell therapy research (4 papers). Uğur Eskiocak is often cited by papers focused on Genetic factors in colorectal cancer (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and CAR-T cell therapy research (4 papers). Uğur Eskiocak collaborates with scholars based in United States, Türkiye and Saudi Arabia. Uğur Eskiocak's co-authors include Woodring E. Wright, Jerry W. Shay, Sang Bum Kim, Andres I. Roig, Sean J. Morrison, Crystal Cornelius, Peter Ly, Suzie K. Hight, Oliver Delgado and Stuart J. Spechler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Uğur Eskiocak

30 papers receiving 920 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Uğur Eskiocak United States	16	610	211	142	118	86	30	938
Ignacio Dolado Spain	11	695 1.1×	333 1.6×	170 1.2×	84 0.7×	60 0.7×	20	1.0k
Zhitu Zhu China	17	595 1.0×	195 0.9×	177 1.2×	58 0.5×	57 0.7×	46	943
Bonnie Andrais Canada	17	633 1.0×	374 1.8×	259 1.8×	113 1.0×	114 1.3×	21	997
Shikha Gaur United States	16	487 0.8×	218 1.0×	206 1.5×	59 0.5×	55 0.6×	28	875
Drew Adams United States	18	706 1.2×	172 0.8×	174 1.2×	57 0.5×	68 0.8×	44	1.1k
Noriko Ueno Japan	16	623 1.0×	177 0.8×	269 1.9×	121 1.0×	33 0.4×	23	1.2k
Salisha Hill United States	16	630 1.0×	170 0.8×	145 1.0×	99 0.8×	44 0.5×	24	939
Fei Chu United States	16	574 0.9×	381 1.8×	181 1.3×	55 0.5×	46 0.5×	34	1.1k
Sarah A. Head United States	14	465 0.8×	133 0.6×	126 0.9×	98 0.8×	41 0.5×	32	854
Chul-Koo Cho South Korea	18	771 1.3×	194 0.9×	147 1.0×	58 0.5×	149 1.7×	20	1.1k

Countries citing papers authored by Uğur Eskiocak

Since Specialization

Citations

This map shows the geographic impact of Uğur Eskiocak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uğur Eskiocak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uğur Eskiocak more than expected).

Fields of papers citing papers by Uğur Eskiocak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uğur Eskiocak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uğur Eskiocak. The network helps show where Uğur Eskiocak may publish in the future.

Co-authorship network of co-authors of Uğur Eskiocak

This figure shows the co-authorship network connecting the top 25 collaborators of Uğur Eskiocak. A scholar is included among the top collaborators of Uğur Eskiocak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uğur Eskiocak. Uğur Eskiocak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Miso, Magali Pederzoli-Ribeil, Uğur Eskiocak, et al.. (2023). XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer. Journal for ImmunoTherapy of Cancer. 11(12). e007785–e007785. 8 indexed citations

Budimir, Natalija, Lina Ma, Simon Shenhav, et al.. (2022). 1123 Preclinical activity and safety profile or JANX008, a novel EGFR-targeting tumor-activated T cell engager for treatment of solid tumors. Regular and Young Investigator Award Abstracts. A1167–A1167. 3 indexed citations

Budimir, Natalija, Simon Shenhav, Hua Wu, et al.. (2022). 1325 Preclinical activity and safety profile of JANX007, a novel PSMA-targeting tumor-activated T Cell engager for treatment of metastatic castration-resistant prostate cancer. Regular and Young Investigator Award Abstracts. A1376–A1376. 7 indexed citations

Zaritsky, Assaf, Andrew R. Jamieson, Erik S. Welf, et al.. (2021). Interpretable deep learning uncovers cellular properties in label-free live cell images that are predictive of highly metastatic melanoma. Cell Systems. 12(7). 733–747.e6. 52 indexed citations

Zhang, Minjie, Uğur Eskiocak, M. A. McLaughlin, et al.. (2020). 587 Tumor-activated Fc-engineered anti-CTLA-4 monoclonal antibody, XTX101, demonstrates tumor-selective PD and efficacy in preclinical models. SHILAP Revista de lepidopterología. A351.2–A351. 2 indexed citations

Kasitinon, Stacy Y., Uğur Eskiocak, Misty Martin, et al.. (2019). TRPML1 Promotes Protein Homeostasis in Melanoma Cells by Negatively Regulating MAPK and mTORC1 Signaling. Cell Reports. 28(9). 2293–2305.e9. 42 indexed citations

Eskiocak, Uğur. (2018). Arrayed shRNA Screening to Identify Suppressors of Anchorage-Independent Growth. Methods in molecular biology. 1907. 115–123. 1 indexed citations

Frankel, Arthur E., Uğur Eskiocak, Jennifer G. Gill, et al.. (2017). Digoxin Plus Trametinib Therapy Achieves Disease Control in BRAF Wild-Type Metastatic Melanoma Patients. Neoplasia. 19(4). 255–260. 38 indexed citations

Potu, Harish, Luke F. Peterson, Malathi Kandarpa, et al.. (2017). Usp9x regulates Ets-1 ubiquitination and stability to control NRAS expression and tumorigenicity in melanoma. Nature Communications. 8(1). 14449–14449. 53 indexed citations

10.

Eskiocak, Uğur, Vijayashree Ramesh, Jennifer G. Gill, et al.. (2016). Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma. Nature Communications. 7(1). 12336–12336. 43 indexed citations

11.

Wang, Meng, et al.. (2015). Therapeutic Synergy from Combined Inhibition of the SERCA Channel and MAPK Signaling Pathway in MAPK-Dependent Leukemia. Blood. 126(23). 1264–1264. 2 indexed citations

12.

Ram, Rosalyn, Saurabh Mendiratta, Brian O. Bodemann, et al.. (2014). RASSF1A Inactivation Unleashes a Tumor Suppressor/Oncogene Cascade with Context-Dependent Consequences on Cell Cycle Progression. Molecular and Cellular Biology. 34(12). 2350–2358. 17 indexed citations

13.

Potu, Harish, Anupama Pal, Hanshi Sun, et al.. (2014). Abstract 4435: Deubiquitinases Usp9x and Usp5 control tumorigenicity and apoptotic responsiveness in malignant melanoma. Cancer Research. 74(19_Supplement). 4435–4435. 2 indexed citations

14.

Eskiocak, Uğur, Sang Bum Kim, Peter Ly, et al.. (2011). Functional Parsing of Driver Mutations in the Colorectal Cancer Genome Reveals Numerous Suppressors of Anchorage-Independent Growth. Cancer Research. 71(13). 4359–4365. 22 indexed citations

15.

Ly, Peter, Uğur Eskiocak, Andres I. Roig, et al.. (2011). Characterization of Aneuploid Populations with Trisomy 7 and 20 Derived from Diploid Human Colonic Epithelial Cells. Neoplasia. 13(4). 348–IN17. 31 indexed citations

16.

Eskiocak, Uğur, et al.. (2011). Short Hairpin RNA Screen Indicates That Klotho Beta/FGF19 Protein Overcomes Stasis in Human Colonic Epithelial Cells. Journal of Biological Chemistry. 286(50). 43294–43300. 9 indexed citations

17.

Zhao, Yong, Eladio Abreu, Guido Stadler, et al.. (2011). Processive and Distributive Extension of Human Telomeres by Telomerase under Homeostatic and Nonequilibrium Conditions. Molecular Cell. 42(3). 297–307. 68 indexed citations

18.

Roig, Andres I., Uğur Eskiocak, Suzie K. Hight, et al.. (2009). Immortalized Epithelial Cells Derived From Human Colon Biopsies Express Stem Cell Markers and Differentiate In Vitro. Gastroenterology. 138(3). 1012–1021.e5. 141 indexed citations

19.

Eskiocak, Uğur, et al.. (2008). Effect of Doxorubicin on Telomerase Activity and Apoptotic Gene Expression in Doxorubicin-Resistant and -Sensitive MCF-7 Cells. Chemotherapy. 54(3). 209–216. 20 indexed citations

20.

Eskiocak, Uğur, et al.. (2008). hTERT gene expression levels and telomerase activity in drug resistant MCF-7 cells.. PubMed. 30(3). 202–5. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact